What is Dawaai?
Dawaai is dedicated to revolutionizing pharmacy services by offering integrated solutions focused on convenience and quality. The company is actively reinventing the traditional retail pharmacy model by ensuring authentic medicines are delivered directly to patients' doorsteps with maximum speed and efficiency. This approach positions Dawaai as a key player in the digital health and pharmaceutical logistics landscape, addressing critical needs for accessible healthcare solutions.
How much funding has Dawaai raised?
Dawaai has raised a total of $8.5M across 1 funding round:
Debt
$8.5M
Debt (2021): $8.5M with participation from Sarmayacar and 500 Global
Key Investors in Dawaai
Sarmayacar
Sarmayacar is Pakistan's largest venture capital firm specializing in technology sector investments, supporting entrepreneurs in building transformative startups across fintech, healthtech, logistics, and more. They focus on markets with significant growth potential and aim to enhance the technology landscape through value-add investments.
500 Global
500 Global, founded in 2010, is a venture capital firm with a global investment portfolio. Headquartered in Mountain View and San Francisco, California, the firm invests in a wide range of companies across various industries and geographies.
What's next for Dawaai?
The substantial enterprise-level funding and strategic investment Dawaai has attracted signal a strong market validation and provide the necessary capital for aggressive expansion and operational enhancement. This financial infusion is expected to fuel the company's growth trajectory, enabling Dawaai to further optimize its supply chain, enhance its technological infrastructure, and broaden its service reach. The company is poised to solidify its position as a leader in delivering convenient and high-quality pharmaceutical services, potentially exploring new market segments and service innovations to meet growing consumer demand for accessible healthcare.
See full Dawaai company page
